Cargando…
Ganglioside GD3 synthase (GD3S), a novel cancer drug target
Gangliosides are a class of important glycosphingolipids containing sialic acid that are widely distributed on the outer surface of cells and are abundantly distributed in brain tissue. Disialoganglioside with three glycosyl groups (GD3) and disialoganglioside with two glycosyl groups (GD2) are mark...
Autores principales: | Liu, Jinyi, Zheng, Xiangjin, Pang, Xiaocong, Li, Li, Wang, Jinhua, Yang, Cui, Du, Guanhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6147802/ https://www.ncbi.nlm.nih.gov/pubmed/30245960 http://dx.doi.org/10.1016/j.apsb.2018.07.009 |
Ejemplares similares
-
The biological role and immunotherapy of gangliosides and GD3 synthase in cancers
por: Cao, Shangqi, et al.
Publicado: (2023) -
GD2 and GD3 synthase: novel drug targets for cancer therapy
por: Sphyris, Nathalie, et al.
Publicado: (2015) -
GD3- and O-acetylated GD3-gangliosides in the GM2 synthase-deficient mouse brain and their immunohistochemical localization
por: Matsuda, Junko, et al.
Publicado: (2006) -
Expression of GD2 and GD3 gangliosides in human embryonic neural stem cells
por: Yanagisawa, Makoto, et al.
Publicado: (2011) -
Acetylation Suppresses the Proapoptotic Activity of GD3 Ganglioside
por: Malisan, Florence, et al.
Publicado: (2002)